Accolade (ACCD) said Wednesday it has agreed to be acquired by Transcarent for $7.03 per share, which it said represents a total equity value of approximately $621 million.
The companies said the acquisition price represents a premium of approximately 110% over Accolade's Tuesday closing stock price.
The companies said Transcarent will finance the transaction through equity financing led by General Catalyst and Glen Tullman's 62 Ventures.
The boards of directors of both companies have unanimously approved the deal, which is expected to close in Q2 following stockholder and regulatory approvals and other customary closing conditions. Upon completion, Accolade will become a privately held company and its stock will no longer be listed on Nasdaq, the companies said.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。